31 results on '"Ying Bei"'
Search Results
2. MP28-04 CLINICAL AND IMMUNOGENOMIC OUTCOMES OF CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
3. MP39-09 GENOMIC CHARACTERIZATION OF AGGRESSIVE SPORADIC EPITHELIOID ANGIOMYOLIPOMA
4. PD16-07 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH OUTCOME AND DIFFERS BETWEEN MOLECULAR SUBGROUPS
5. PD40-05 NEOADJUVANT IMMUNOTHERAPY IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY
6. PD16-07 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH OUTCOME AND DIFFERS BETWEEN MOLECULAR SUBGROUPS
7. Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer
8. PD47-01 GENOMIC DETERMINANTS OF NESTED VARIANT UROTHELIAL CARCINOMA
9. MP18-06 CLINICOPATHOLOGIC IMPLICATIONS OF ATYPICAL SMALL ACINAR PROLIFERATION (ASAP) IN THE ERA OF ACTIVE SURVEILLANCE
10. MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS
11. PD46-04 ELOC-MUTATED RENAL CELL CARCINOMA: A DISTINCT CLINICAL ENTITY WITH UNCLEAR DISEASE COURSE
12. MP18-06 CLINICOPATHOLOGIC IMPLICATIONS OF ATYPICAL SMALL ACINAR PROLIFERATION (ASAP) IN THE ERA OF ACTIVE SURVEILLANCE
13. Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer
14. Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer
15. MP48-03 INTRATUMORAL HETEROGENEITY OF ERBB2 AMPLIFICATION AND HER2 EXPRESSION IN MICROPAPILLARY UROTHELIAL CARCINOMA
16. MP39-04 MOLECULAR AND CLINICAL CHARACTERIZATION OF RENAL CELL CARCINOMA WITH UNCLASSIFIED HISTOLOGY: NF2 LOSS PREDICTS WORST OUTCOMES
17. Initial Atypical Diagnosis With Carcinoma on Subsequent Prostate Needle Biopsy: Findings at Radical Prostatectomy
18. MP48-03 INTRATUMORAL HETEROGENEITY OF ERBB2 AMPLIFICATION AND HER2 EXPRESSION IN MICROPAPILLARY UROTHELIAL CARCINOMA
19. MP69-18 GENETIC CHARACTERIZATION OF METASTATIC RENAL CELL CARCINOMA LACKING PRIMARY RENAL MASS
20. MP35-19 SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC)
21. PD15-01 CHARACTERIZING THE DOMINANT/INDEX LESION IN PROSTATE CANCER: IMPLICATIONS FOR GRADING AND STAGING
22. MP23-16 TCEB1 -MUTATED RENAL CELL CARCINOMA: A DISTINCT GENOMIC AND MORPHOLOGIC SUBTYPE
23. 1068 ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
24. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma
25. 1732 ATYPICAL GLANDS SUSPICIOUS FOR CARCINOMA FOLLOWED BY THE DIAGNOSIS OF CARCINOMA ON PROSTATE NEEDLE BIOPSY: FINDINGS AT RADICAL PROSTATECTOMY (RP)
26. MP23-16 TCEB1 -MUTATED RENAL CELL CARCINOMA: A DISTINCT GENOMIC AND MORPHOLOGIC SUBTYPE
27. MP35-19 SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC)
28. PD15-01 CHARACTERIZING THE DOMINANT/INDEX LESION IN PROSTATE CANCER: IMPLICATIONS FOR GRADING AND STAGING
29. 1068 ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
30. Initial Atypical Diagnosis With Carcinoma on Subsequent Prostate Needle Biopsy: Findings at Radical Prostatectomy
31. 1732 ATYPICAL GLANDS SUSPICIOUS FOR CARCINOMA FOLLOWED BY THE DIAGNOSIS OF CARCINOMA ON PROSTATE NEEDLE BIOPSY: FINDINGS AT RADICAL PROSTATECTOMY (RP)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.